Health Tech & You Reveals First Set of Finalists

1 January 0001

Category Finalists

Ground-breaking innovations announced

The finalists from two of this year’s AXA Health Tech & You Awards categories have been announced today. The Innovations in the Early Diagnosis of Dementia Award is in partnership with Alzheimer’s Research UK and the Women in Health Tech Entrepreneurs award is partnering with Our Mobile Health and Collider Health. The former category is identifying the latest health tech to help with the early diagnosis of dementia and the latter, showcasing tech pioneered by female developers

Since these categories were opened at the launch of Year 4 of AXA Health Tech & You in October 2017, there has been a relentless pursuit to discover new and emerging health tech, culminating in over 75 entries, which have now been shortlisted to just three per category. The categories are:

Innovations in the Early Diagnosis of Dementia Award, in partnership with Alzheimer’s Research UK, aims to identify the development of technology innovation and design that can support the diagnosis of diseases underpinning dementia. The category finalists are:

  • Wearable devices and disease-specific mobile apps to provide remote patient monitoring, capturing subtle differences in ambulation and sleeping patterns to help detect early signs of dementia
  • A 5-minute integrated cognitive assessment tool that tests the performance of large areas of the brain and has the potential to be a highly effective dementia screening tool
  • A concept-stage system that aims to detect changes in physical and social behaviour as an early indicator for dementia.

Women in Health Tech Entrepreneurs Award celebrates and supports women pioneering innovative health technology, working with Our Mobile Health and Collider Health, Women of Wearable and One Health Tech UK to showcase and encourage female entrepreneurs in the health tech arena. The category finalists are:

  • A smart glove which translates sign language to text and speech, enabling communication for non-verbal individuals
  • Postural support system for wheelchair users to empower them to be more independent in their daily lives
  • Wearable that detects prolonged phases of shallow breathing, alerts the user and helps regulate breaths to improve stress resilience.

Richard Cooper, Head of Digital & E-Commerce, AXA PPP healthcare, states:

“We are very excited about the ground-breaking innovations coming through these two new categories marking the fourth year of AXA Health Tech & You. The Innovations in the Early Detection of Dementia Award addresses a real need for health tech to help detect the early signs of dementia, speeding up a formal diagnosis and giving symptom-lessening treatments the chance to make a difference to people’s quality of life.”

To align with the Women in Health Tech Entrepreneurs categories, an OnePoll survey¹ was commissioned looking at people’s perceptions of women in the tech industry. The survey found that over half (53%) of people surveyed felt the tech industry was male-dominated, with 66% saying that employing more women in the tech sector would attract more female applicants. To encourage women to start a business in the technology sector, 43% said that more girls/women should be encouraged to study STEM subjects, with 55% of men and women surveyed feeling that more women entering the tech sector would help to develop better solutions.

“We are proud to be celebrating female entrepreneurs in the health tech space, showcasing innovative devices designed by women. From monitoring breathing to help combat stress, to solutions that encourage increased inclusivity and everyday comfort for people managing conditions, we’ve seen some inspirational and consumer-focused innovations coming through the Women in Health Tech Entrepreneurs Award category.

“We would like to thank our category partners and everyone who entered this year’s Awards. We congratulate those who have been shortlisted and look forward to revealing the winners at the Awards ceremony in May”, added Cooper.

The shortlisted finalists from four Challenge categories will be announced at the beginning of May and all category winners will be announced at a prestigious Awards ceremony to be held at the Royal College of General Practitioners in London on 9th May 2018. All 18 finalists will be showcased at an exclusive Media Preview at the same venue also on 9th May.

For more information on this year’s finalists, judges and activities, visit www.healthtechandyou.com.

Innovations in the Early Diagnosis of Dementia Award
  • Cognetivity
    A 5-minute integrated cognitive assessment tool (ICA) that looks for the earliest signs of impairment by testing the performance of large areas of the brain. The ICA is easy to administer and can learn as it gathers new data to improve its ability to diagnose. As well as having the potential to be a highly effective dementia screening tool, the ICA can also be used for remote monitoring of the progression of diseases and measuring the effectiveness of treatments. (www.cognetivity.com)

  • Aparito 
    A digital health platform that provides wearable devices and disease-specific mobile apps to provide remote patient monitoring outside of the hospital environment. This continued monitoring provides real-time data for clinicians to capture subtle differences in ambulation and sleeping patterns, that can’t be conveyed during short, snap shot clinic visits in a way that actively supports and enhances diagnosis, treatment and drug development. Aparito are also developing a tool which can measure differences in speech patterns. (www.aparito.com)

  • Memrica
    A system in the concept stage that aims to detect changes in physical and social behaviour as an early indicator for dementia. Memrica has been reviewing previous research on multiple indicators and is certain there's an opportunity to bring currently separate strands of thinking and analysis together to create a simple indicator of risk. (www.memricaprompt.com)

 

Women in Health Tech Entrepreneurs Award
  • BrightSign
    Smart glove which translates sign language to text and speech. BrightSign enables the direct interaction between sign language users and the general public by providing two-way communication which eliminates the need for an accompanying interpreter or family member. It is equipped with machine learning software which allows each user to train the glove to their custom signs and individual variations of the sign language library. BrightSign is paired with an app to enable the user to choose the speech language of the glove (English, French, Arabic, etc.) so it can be used in many countries. (www.brightsignglove.com)

  • iBreve
    A wearable device which helps people to improve their stress resilience by analysing breathing patterns in real-time. It detects prolonged phases of shallow breathing, optimises the respiratory rate and guides through breathing and relaxation exercises. iBreve focuses initially on women's health & well-being and can be easily attached to any regular bra. A machine-learning algorithm correlates breathing rate, activity and stress level and can trigger a subtle vibration directly on the device or send a notification to the user’s phone. (www.ibreve.com)

  • Aergo
    The world's most responsive postural support system for wheelchair users, empowering users to be more independent in their daily lives. The remote-controlled system adjusts inflatable air cells to provide support for a range of physical conditions. It is the first device of its kind to grow with the user through its expandable frame. Aergo has been user-tested with young patients from the neuromuscular division of Alder Hey Children’s Hospital and numerous local schools. (www.aergo.co.uk)

Shortlisted finalists from the four Challenge categories above, will be announced in early May

 

Further information

Notes to editors

Enquiries

 

Ben Faulkner/John DuBois AXA PPP healthcare press office 01892 612822

About AXA PPP healthcare

AXA PPP healthcare – one of the largest and most experienced private medical insurance providers in the UK – has been helping people to access healthcare services since 1940. Today it forms the UK healthcare arm of AXA and provides cover for medical and dental care for individuals and employers, and employee wellbeing, counselling, occupational health and rehabilitation services through its specialist Health Services division.        AXA PPP healthcare has been named the Best Healthcare Provider for three years running in the Your Money Awards and, in June 2015, was awarded the prestigious accolade of European Large Contact Centre of the Year at the 2015 European Contact Centre & Customer Service Awards, followed in September 2015 by the Best Customer Experience accolade in the Large Contact Centre category of the UK Customer Experience Awards 2015.

About AXA

The AXA Group is a worldwide leader in insurance and asset management, with 166,000 employees serving 107 million clients in 64 countries. In 2016, IFRS revenues amounted to Euro 100.2 billion and IFRS underlying earnings to Euro 5.7 billion. AXA had Euro 1,429 billion in assets under management as of December 31, 2016. In 2016 Interbrand ranked AXA the 1st insurance brand worldwide for the 8th consecutive year.

In the UK AXA operates through a number of business units including: AXA Insurance, AXA PPP healthcare and AXA Ireland. AXA employs over 10,000 staff in the UK. The AXA ordinary share is listed on compartment A of Euronext Paris under the ticker symbol CS (ISN FR 0000120628 – Bloomberg: CS FP – Reuters: AXAF.PA). AXA’s American Depository Share is also quoted on the OTC QX platform under the ticker symbol AXAHY. 

The AXA Group is included in the main international SRI indexes, such as Dow Jones Sustainability Index (DJSI) and FTSE4GOOD.

It is a founding member of the UN Environment Programme’s Finance Initiative (UNEP FI) Principles for Sustainable Insurance and a signatory of the UN Principles for Responsible Investment.